NCT07737327

Brief Summary

The aim of this research is to determine whether sodium citrate supplementation, taken at the best individual time, would improve repeated sprint performance in professional female soccer players. The main questions it aims to answer are:

  1. 1.Does sodium citrate improve sprint times, peak power, minimum power, and mean power during repeated sprints?
  2. 2.Does sodium citrate lower fatigue index (the drop in power across sprints) during repeated sprint exercise?
  3. 3.Does sodium citrate change blood bicarbonate, pH, and lactate levels before and after exercise?
  4. 4.Does sodium citrate affect how hard exercise feels (perceived exertion)?

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
6mo left

Started Aug 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 27, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 30, 2026

Completed
21 days until next milestone

Study Start

First participant enrolled

August 20, 2026

Expected
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2026

2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Last Updated

July 30, 2026

Status Verified

July 1, 2026

Enrollment Period

3 months

First QC Date

July 27, 2026

Last Update Submit

July 27, 2026

Conditions

Keywords

Sodium citrateBuffering agentRepeated sprint performanceFemale athletesSoccerAnaerobic performanceBlood bicarbonateIndividualized timing

Outcome Measures

Primary Outcomes (2)

  • Minimum Power

    The lowest power output recorded across six maximal 35-meter sprints during the Running-based Anaerobic Sprint Test (RAST). Calculated as body weight (kg) multiplied by the square of sprint distance (m) divided by the cube of the slowest sprint time (s).

    Measured during the RAST test, administered immediately after the individualized ingestion-to-exercise interval (T_peak for sodium citrate; 120-150 minutes post-ingestion for placebo)

  • Fatigue Index

    The rate of power decline across six maximal 35-meter sprints during the Running-based Anaerobic Sprint Test (RAST). Calculated as the difference between peak power and minimum power divided by total sprint time (W/s).

    Measured during the RAST test, administered immediately after the individualized ingestion-to-exercise interval (T_peak for sodium citrate; 120-150 minutes post-ingestion for placebo)

Secondary Outcomes (7)

  • Peak Power

    Measured during the RAST test, administered immediately after the individualized ingestion-to-exercise interval (T_peak for sodium citrate; 120-150 minutes post-ingestion for placebo)

  • Mean Power

    Measured during the RAST test, administered immediately after the individualized ingestion-to-exercise interval (T_peak for sodium citrate; 120-150 minutes post-ingestion for placebo)

  • Sprint Times

    Measured during the RAST test, administered immediately after the individualized ingestion-to-exercise interval (T_peak for sodium citrate; 120-150 minutes post-ingestion for placebo)

  • Blood Bicarbonate Concentration

    Measured at baseline (pre-ingestion), pre-exercise (at T_peak for sodium citrate; 120-150 minutes post-ingestion for placebo), and at 1, 3, 5, and 7 minutes post-exercise.

  • Blood pH

    Measured at baseline (pre-ingestion), pre-exercise (at T_peak for sodium citrate; 120-150 minutes post-ingestion for placebo), and at 1, 3, 5, and 7 minutes post-exercise.

  • +2 more secondary outcomes

Study Arms (2)

Sodium Citrate

EXPERIMENTAL

Participants will ingest sodium citrate at a dose of 0.5 g/kg body weight dissolved in flavored water. Capillary blood sampling will begin 90 minutes post-ingestion and continue at regular intervals. Exercise will begin when blood bicarbonate concentration reaches its individual peak (T\_peak).

Dietary Supplement: Sodium Citrate Oral Product

Placebo

EXPERIMENTAL

Participants will ingest sodium chloride (NaCl) at a taste-matched dose. Exercise will begin 120-150 minutes post-ingestion, consistent with the expected digestion timeline and the typical T\_peak window observed with sodium citrate supplementation.

Other: Placebo

Interventions

Sodium Citrate Oral ProductDIETARY_SUPPLEMENT

0.5 g/kg body weight of sodium citrate dissolved in flavored water, ingested orally. Exercise begins at individual peak blood bicarbonate time (T\_peak), determined through serial capillary blood sampling starting 90 minutes post-ingestion.

Also known as: Trisodium citrate
Sodium Citrate
PlaceboOTHER

Sodium chloride (NaCl) at a taste-matched dose dissolved in flavored water, ingested orally. Exercise begins 120-150 minutes post-ingestion.

Also known as: Sodium Chloride, NaCl
Placebo

Eligibility Criteria

Age18 Years - 25 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale only.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Female professional soccer players competing in the Turkish Women's Third League
  • Age between 18-25 years
  • Active training status (minimum 3 sessions per week)
  • Regular menstrual cycles
  • Both experimental trials scheduled in the same phase of the menstrual cycle, outside of menstruation
  • No use of nutritional supplements in the 4 weeks prior to the study
  • Willingness to provide written informed consent

You may not qualify if:

  • Use of oral contraceptives
  • Irregular menstrual cycle
  • History of gastrointestinal disorders
  • Any musculoskeletal injury preventing maximal sprint performance
  • Smoking
  • Use of any medication that may affect acid-base balance
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (18)

  • Peacock J, Sparks SA, Middlebrook I, Hilton NP, Tinnion D, Leach N, Saunders B, McNaughton LR. Extracellular buffer choice influences acid-base responses and gastrointestinal symptoms. Res Sports Med. 2021 Nov-Dec;29(6):505-516. doi: 10.1080/15438627.2021.1896517. Epub 2021 Mar 9.

    PMID: 33715526BACKGROUND
  • Lancha Junior AH, Painelli Vde S, Saunders B, Artioli GG. Nutritional Strategies to Modulate Intracellular and Extracellular Buffering Capacity During High-Intensity Exercise. Sports Med. 2015 Nov;45 Suppl 1:S71-81. doi: 10.1007/s40279-015-0397-5.

    PMID: 26553493BACKGROUND
  • McNulty KL, Elliott-Sale KJ, Dolan E, Swinton PA, Ansdell P, Goodall S, Thomas K, Hicks KM. The Effects of Menstrual Cycle Phase on Exercise Performance in Eumenorrheic Women: A Systematic Review and Meta-Analysis. Sports Med. 2020 Oct;50(10):1813-1827. doi: 10.1007/s40279-020-01319-3.

    PMID: 32661839BACKGROUND
  • Miller P, Robinson AL, Sparks SA, Bridge CA, Bentley DJ, McNaughton LR. The Effects of Novel Ingestion of Sodium Bicarbonate on Repeated Sprint Ability. J Strength Cond Res. 2016 Feb;30(2):561-8. doi: 10.1519/JSC.0000000000001126.

    PMID: 26815179BACKGROUND
  • Heibel AB, Perim PHL, Oliveira LF, McNaughton LR, Saunders B. Time to Optimize Supplementation: Modifying Factors Influencing the Individual Responses to Extracellular Buffering Agents. Front Nutr. 2018 May 8;5:35. doi: 10.3389/fnut.2018.00035. eCollection 2018.

    PMID: 29868599BACKGROUND
  • McNaughton LR. Sodium citrate and anaerobic performance: implications of dosage. Eur J Appl Physiol Occup Physiol. 1990;61(5-6):392-7. doi: 10.1007/BF00236058.

    PMID: 2079058BACKGROUND
  • McNaughton L, Cedaro R. Sodium citrate ingestion and its effects on maximal anaerobic exercise of different durations. Eur J Appl Physiol Occup Physiol. 1992;64(1):36-41. doi: 10.1007/BF00376437.

    PMID: 1735409BACKGROUND
  • Urwin CS, Snow RJ, Orellana L, Condo D, Wadley GD, Carr AJ. Does varying the ingestion period of sodium citrate influence blood alkalosis and gastrointestinal symptoms? PLoS One. 2021 May 17;16(5):e0251808. doi: 10.1371/journal.pone.0251808. eCollection 2021.

    PMID: 33999939BACKGROUND
  • Tortu E, Hazir T, Kin-Isler A. Energy System Contributions in Repeated Sprint Tests: Protocol and Sex Comparison. J Hum Kinet. 2024 Feb 17;92:87-98. doi: 10.5114/jhk/175862. eCollection 2024 Apr.

    PMID: 38736607BACKGROUND
  • Tiryaki GR, Atterbom HA. The effects of sodium bicarbonate and sodium citrate on 600 m running time of trained females. J Sports Med Phys Fitness. 1995 Sep;35(3):194-8.

    PMID: 8775646BACKGROUND
  • Oopik V, Timpmann S, Kadak K, Medijainen L, Karelson K. The Effects of Sodium Citrate Ingestion on Metabolism and 1500-m Racing Time in Trained Female Runners. J Sports Sci Med. 2008 Mar 1;7(1):125-31. eCollection 2008.

    PMID: 24150144BACKGROUND
  • McManus CJ, Liew BXW, Waterworth SPW, Chung HC. Intra-individual reliability of blood bicarbonate responses and gastrointestinal symptoms following sodium citrate supplementation. J Int Soc Sports Nutr. 2026 Dec 31;23(1):2629830. doi: 10.1080/15502783.2026.2629830. Epub 2026 Feb 9.

    PMID: 41661559BACKGROUND
  • Carr AJ, McKay AKA, Burke LM, Smith ES, Urwin CS, Convit L, Jardine WT, Kelly MK, Saunders B. Use of Buffers in Specific Contexts: Highly Trained Female Athletes, Extreme Environments and Combined Buffering Agents-A Narrative Review. Sports Med. 2023 Dec;53(Suppl 1):25-48. doi: 10.1007/s40279-023-01872-7. Epub 2023 Oct 25.

    PMID: 37878211BACKGROUND
  • Urwin CS, Snow RJ, Condo D, Snipe R, Wadley GD, Carr AJ. Factors Influencing Blood Alkalosis and Other Physiological Responses, Gastrointestinal Symptoms, and Exercise Performance Following Sodium Citrate Supplementation: A Review. Int J Sport Nutr Exerc Metab. 2021 Mar 1;31(2):168-186. doi: 10.1123/ijsnem.2020-0192. Epub 2021 Jan 13.

    PMID: 33440332BACKGROUND
  • Tinnion DJ, Dobson B, Hilton N, McNaughton LR, Sparks SA. The Magnitude of the Blood Acid-Base Response, but Not Time to Peak, Is Reliable Following the Ingestion of Acute, Individualized Sodium Citrate. Int J Sport Nutr Exerc Metab. 2024 Nov 22;35(2):131-139. doi: 10.1123/ijsnem.2024-0122. Print 2025 Mar 1.

    PMID: 39577403BACKGROUND
  • Bishop D, Edge J. Determinants of repeated-sprint ability in females matched for single-sprint performance. Eur J Appl Physiol. 2006 Jul;97(4):373-9. doi: 10.1007/s00421-006-0182-0. Epub 2006 Apr 13.

    PMID: 16612646BACKGROUND
  • Adam B, Liebregts T, Saadat-Gilani K, Vinson B, Holtmann G. Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia. Aliment Pharmacol Ther. 2005 Aug 15;22(4):357-63. doi: 10.1111/j.1365-2036.2005.02572.x.

    PMID: 16098003BACKGROUND
  • Kuru D, Aktitiz S, Atakan MM, Kose MG, Turnagol HH, Kosar SN. Effect of Pre-exercise Sodium Citrate Ingestion on Repeated Sprint Performance in Soccer Players. J Strength Cond Res. 2024 Mar 1;38(3):556-562. doi: 10.1519/JSC.0000000000004651. Epub 2024 Jan 19.

    PMID: 38241467BACKGROUND

Related Links

MeSH Terms

Interventions

trisodium citrateSodium Chloride

Intervention Hierarchy (Ancestors)

ChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Officials

  • Hüseyin Hüsrev TURNAGÖL, Professor

    Hacettepe University, Faculty of Sport Sciences

    PRINCIPAL INVESTIGATOR
  • Muhammed M Atakan, Associate Professor

    Hacettepe University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dilara KURU, PhD Candidate

CONTACT

Hüseyin Hüsrev TURNAGÖL, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
The lead researcher managed randomization and was not involved in blood sampling or performance testing. Participants and the blood-sampling investigator were blinded to treatment allocation.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Each participant will complete both the sodium citrate and placebo trials in a randomized order, with a washout period of at least three days between trials.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 27, 2026

First Posted

July 30, 2026

Study Start (Estimated)

August 20, 2026

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

February 1, 2027

Last Updated

July 30, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to participant confidentiality and the absence of institutional data sharing infrastructure.